Thursday, September 1, 2016

BRIEF-As One buys 68,500 shares back in August

* Says it bought back 68,500 shares for 279.6 million yen in

August

Read more

BRIEF-Taiwan's Golden Biotech signs MOU with S.Korea's Handok on medicine, health food development

* Says it signs mou with South Korea's Handok on

medicine and health food development

Read more

UK government condemns "irresponsible" English 5-day doctor strike

LONDON, Sept 1 (Reuters) - British Health Secretary Jeremy

Hunt on Thursday condemned as "totally irresponsible" a plan by

English junior doctors to hold a five-day strike after the

industry's trade union escalated a long-running dispute with the

government.

Read more

UPDATE 1-Novo Nordisk CEO Lars Rebien Sorensen to step down by end-2016

COPENHAGEN, Sept 1 (Reuters) - Lars Rebien Sorensen, chief

executive of the world's largest insulin maker Novo Nordisk

, will step down by the end of 2016 after 16 years in

the job, the Danish company said on Thursday.

Read more

UPDATE 1-Nestle to buy medical device company Phagenesis in stages

ZURICH, Sept 1 (Reuters) - Nestle announced a deal

on Thursday to buy Phagenesis, a British medical device company

working on a new treatment for dysphagia, a condition where

patients are unable to swallow safely.

Read more

BRIEF-PZ Cormay H1 net result turns to profit of 1.1 million zlotys

* Reported on Wednesday H1 revenue of 44.1 million zlotys

($11.27 million) versus 21.3 million zlotys year ago

Read more

RPT-Novo Nordisk CEO Lars Rebien Sorensen to step down by end 2016

COPENHAGEN, Sept 1 (Reuters) - Danish insulin maker Novo

Nordisk's Chief Executive Lars Rebien Sorensen will

step down by the end of 2016 after 16 years in the position, it

said on Thursday.

Read more